Webinar: The Future of Cannabis in Canada
Join VALENS GroWorks for Webinar That Dives into the Mind of the Canadian Cannabis Consumer
Kelowna, British Columbia- Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens“), is hosting a free webinar to discuss the findings of a new study – The Future of Cannabis in Canada.
The study, conducted with Resonance Consultancy, a leading advisor on tourism, real estate and economic development, looks at how legalization has affected attitudes toward consumption, develops a profile of current cannabis consumers, and identifies how and where Canadians plan to consume cannabis in the future.
“This legal industry is so new, that everyone is clamoring for real industry data and market intelligence,” said Everett Knight, Executive Vice President of Strategy and Investments, Valens GroWorks. “So this webinar is for anyone who is interested in understanding exactly who the Canadian consumer is, including Canadian citizens, cannabis professionals, politicians, entrepreneurs and investors. As the first G7 Country to legalize cannabis, Canada has become closely watched by the rest of the world – so this information would even be helpful for the American and European marketplace.”
Legalization of cannabis in Canada has fundamentally changed how Canadians perceive and consume the plant. Among the 27 percent of Canadian adults who say they have consumed cannabis in the past year, 84 percent have consumed cannabis since legalization – which amounts to 23 percent of the Canadian public. Additionally, nearly one-third (23 percent) of Canadian adults are likely to use any form of cannabis in the next year.
Kayla Mann, Business Development and Marketing Manager at Valens GroWorks – and host of the Company’s popular podcast, Extracted with Kayla & Chris - will moderate the webinar which will feature Everett Knight, and Chris Fair, President & CEO of Resonance Consultancy.
“For anyone looking to participate in the market, be it as a consumer, an entrepreneur, an investor or as an advocate, should listen to the webinar,” said Mr. Fair. “We’ll be showcasing some of the high-level findings for the consumer today, as well as forecasting what the next year will bring. Canada is such a dynamic market, and the ‘Second Coming’ of cannabis legalization this October will bring added interest – and money – into the market.”
The webinar will take place on Wednesday May 15th at 3:00 PM ET. Please click here (http://public.viavid.com/index.php?id=134622) to sign up
About Resonance Consultancy:
Resonance Consultancy specializes in research, development strategy, place branding and place marketing that shapes the future of countries, cities, and communities. Based in Vancouver and New York, the 18 employees at Resonance have completed more than 100 research reports, development strategies, business plans and branding projects for real estate developers, tourism organizations and governments in more than 75 countries.
About Valens GroWorks:
Valens GroWorks Corp. is a research-driven, Canadian cannabis company focused on downstream secondary extraction methodology, distillation and cannabinoid isolation and purification, as well as associated quality testing with three wholly-owned subsidiaries located in and around Kelowna, BC. Subsidiary Valens Agritech (“VAL”) holds a license to cultivate cannabis and produce cannabis oil under the Cannabis Act, as well as a license to conduct analytical testing for the cannabis industry. VAL currently has extraction processing and supply agreements with various leading producers across Canada. Subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant Based Science. Subsidiary Valens Farms is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP) standards, ensuring the product from this facility can be exported anywhere in the world where Cannabis is nationally legal for medical or adult usage purposes. For more information, please visit http://valensgroworks.com. The Company’s investor deck can be found specifically at http://valensgroworks.com/investors/
For further information, please contact:
Scott Young
Valens GroWorks Corp.
Telephone: +1.705.888.2756
U.S. / Europe Investors
KCSA Strategic Communications
Phil Carlson / Elizabeth Barker
VGW@kcsa.com
212.896.1233 / 212.896.1203
Media
KCSA Strategic Communications
Anne Donohoe
adonohoe@kcsa.com
212.896.1265
Notice regarding Forward Looking Statements
This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “anticipates”, “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, “positioned” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.
